RedHill seeks to collaborate with pharmaceutical companies with a proven R&D track record and strong commercial capabilities.

RedHill is seeking commercialization and development partners for its products outside the U.S. 

RedHill also seeks to in-license or acquire FDA approved products, marketed in the U.S., in the therapeutic areas of gastrointestinal diseases, primary care and other indications.

If you are interested in exploring partnering, licensing and business development opportunities with RedHill, please contact:

Adi Frish, Chief Corporate & Business Development Officer

Tel.: +972 (0)3 541 3138

Upcoming Events & Presentations

For upcoming conferences and meetings, please visit the Investors section.